Global Wellness Signs Custom Manufacturing Agreement with Hempsana Holdings

Vancouver, British Columbia, August 2, 2022 – Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt:O3X4) (OTCQB: GWSFF) (“Global” or the “Company”) today announced that it has entered into a custom manufacturing agreement with Ontario based Health Canada standard processing licensor Hempsana Holdings Ltd. (CSE: HMPS) to launch cannabis and cannabidiol formulated products into Canada for GWS’ partners’ brands.

Hempsana has submitted 28 products and SKUs on behalf of Global Wellness and the Company partners’ brands to the Ontario Cannabis Store and awaits updates and approval on this first stage of submissions. Under the terms of the agreement, Hempsana has agreed to manufacture approved consumer products by GWS brands. Hempsana will be responsible for providing high-quality cannabis extracts, filling, packaging, and manufacturing services. A predetermined wholesale price will be earned as a fee by Hempsana for the manufacturing, shipping, and sale of the product; in addition, a brokerage fee will be earned on monthly revenue. GWS will receive revenues upon the sale of products to the various provincial cannabis regulators.

“We believe many of these products will satisfy the unmet needs of consumers looking for products with novel delivery methods, new topical applications plus plant based approved ingredients. Our partners are focused on data-driven and science-backed research to introduce their products to Canada,” said Meris Kott, CEO of Global Wellness Strategies Inc.

About Hempsana Holdings Ltd.

The Company’s business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables and edibles. Hempsana’s Health Canada Standard Processing Licensed, and EU-GMP compliant facility provides the Company with access to wholesale and retail channels in Canada and internationally.

Corporate Update:

Global Wellness Strategies signed a public relations contract with Think Ink Marketing to provide a public relations outreach program for the Company. GWS has agreed to pay Think Ink a fee of $50,000USD for their services. Think Ink Marketing Data & Email Services, Inc. is a California-based marketing firm, established in 2013, that provides its customers with a complete range of marketing services that span both digital and direct mail venues. With its digital services ranging from data appending, email marketing, and pay-per-click online banner and native ads, the company helps its clients to reach a large network of potential investors. The Company has paid its renewal contract signed in January with Captios Partners Inc. for marketing and branding of the company’s consumer product goods via debt settlement for their yearly monthly fee of $12,500 CDN in common shares at a price per share of .10.

“In a volatile market, public relations and market awareness is pivotal in differentiating a growing company to investors. We look forward to expanding our shareholder base and a building an international brand as a tri-listed security in Canada, the USA and Germany.” Stated Meris Kott, CEO Global Wellness Strategies Inc. (CSE: GWS) (Frankfurt:O3X4) (OTCQB: GWSFF)

About Global Wellness Strategies

Global Wellness Strategies is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The focus of the Company is on global wellness, psychedelics, mycology, hemp and CBD, healthcare-related target companies

For further information visit websites:

 www.globalwellnessstrategies.com

Or Contact Meris Kott CEO 604.484.0355 or email to info@globalwellnessstrategies.com

Further information about the Company is available on www.SEDAR.com under the Company’s profile.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain statements contained in this release may constitute “forward–looking statements” or “forward-looking information” (collectively “forward-looking information”) as those terms are used in the Private Securities Litigation Reform Act of 1995 and similar Canadian laws. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated”, “anticipates” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the business of the Company, its financing and certain corporate changes. The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Announcement

Breaking
News

NOVEMBER 17, 2022

Global Wellness Strategies Forms Pharma Subsidiary

Focused on Clinical Trials